Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ablynx
Biotech
Sanofi cuts programs tied to multibillion-dollar deals
Sanofi scratched out entries for prospects linked to the multibillion-dollar takeovers of Ablynx, Principia Biopharma and Synthorx.
Nick Paul Taylor
Jan 30, 2025 9:05am
Sanofi cuts staff in Belgium as early-stage research dwindles
Apr 19, 2024 11:34am
Sanofi, after $8B outlay, sees M&A strategy deliver 2 more duds
Apr 27, 2023 7:41am
SynOx taps chief medical, tech officers week after CEO hire
Aug 3, 2021 12:44pm
Hoping to win where Novartis failed, Inhibrx files for $75M IPO
Jun 4, 2019 9:26am
Confo raises €30M series A round to target hard-to-drug GPCRs
May 7, 2019 7:00am
